Michael Firer

Michael Firer

Apr 18, 2022

Group 6 Copy 18
0

How do APS antibodies induce blood clotting?

While there is still debate on the actual mechanism that results in blood clotting in patients with APS, it is agreed that the binding of APS antibodies to cell membrane-bound Beta 2-Glycoprotein 1 on platelets, neutrophils and endothelial cells, triggeres intracellular events resulting in release of factors that trigger inflammation and and blood clotting


0 comments

Join the conversation!Sign In

About This Project

Anti-Phospholipid Syndrome (APS) is an autoimmune disease in which certain antibodies cause blood clotting. These antibodies are an important cause of spontaneous miscarriage in women aged 20-50 years. There is no effective treatment for APS. Our project will test whether small peptides we have discovered, can block the activity of these antibodies. Positive results from these experiments will support further development of the peptides as a new therapy for APS.

More Lab Notes From This Project

Blast off!

Browse Other Projects on Experiment

Related Projects

Developing a new tissue preservation method inspired by Tardigrades

There are two routine ways to preserve tissues: formalin-fixed paraffin-embedded preservation (FFPE) and...

New bioactive peptides from skin of a colombian frog

The search for alternative antibiotics is on, due to widespread resistance to current antibiotics. We will...

A robust and clinical-friendly CRISPR diagnostic test kit for rapid SARS-COV2 detection

The high specificity and sensitivity of the CRISPR diagnostics, e.g. SHERLOCK, can detect the presence of...

Add a comment